Showing results (161-170 of 203) with videos related to

Sort By:
Pageof 21
Melanoma Research|September 11, 2023
Safety of immune checkpoint inhibitors after proton beam therapy in head and neck mucosal melanoma: a case seriesMao Uematsu, Hiromichi Nakajima, Ako Hosono, et al.
International Journal of Clinical Oncology|June 21, 2023
Potential efficacy of local therapy for progressive lesions after nivolumab in patients with recurrent or metastatic squamous cell carcinoma of the head and neckMasanobu Sato, Tomohiro Enokida, Akihisa Wada, et al.
Oral Oncology|March 9, 2025
Induction chemotherapy and concurrent chemoradiotherapy with cisplatin for T4 nasoethmoidal squamous cell carcinoma: The value of paclitaxel, carboplatin and cetuximab (PCE)Nobukazu Tanaka, Tomohiro Enokida, Susumu Okano, et al.
Anticancer Research|June 26, 2024
Autologous Peripheral Blood Stem Cell Transplantation and Timing of Local Radiation Therapy in Patients With Malignant Lymphoma: Results of the Japanese Radiation Oncology Study Group Questionnaire SurveyNaoya Ishibashi, Yasuo Ejima, Toshinori Soejima, et al.
Cancer Chemotherapy and Pharmacology|January 2, 2021
FOLFIRINOX in advanced pancreatic cancer patients with the double-variant type of UGT1A1 *28 and *6 polymorphism: a multicenter, retrospective studyKumiko Umemoto, Hideaki Takahashi, Chigusa Morizane, et al.
Advances in Radiation Oncology|June 23, 2021
Multi-Institutional Retrospective Analysis of the Outcomes of Proton Beam Therapy for Patients With 1 to 3 Pulmonary Oligometastases From Various Primary CancersNorihiro Aibe, Hiroyuki Ogino, Satoshi Teramukai, et al.
Cancer Science|March 18, 2015
Phase II trial of chemoradiotherapy with S-1 plus cisplatin for unresectable locally advanced head and neck cancer (JCOG0706)Makoto Tahara, Naomi Kiyota, Junki Mizusawa, et al.
Clinical & Experimental Metastasis|July 19, 2023
Prognostic impact of EGFR/ALK alterations in leptomeningeal metastasis from lung adenocarcinoma treated with whole-brain radiotherapyHidekazu Oyoshi, Hidenari Hirata, Yasuhiro Hirano, et al.
Radiation Oncology (London, England)|June 24, 2020
Radiobiological model-based approach to determine the potential of dose-escalated robust intensity-modulated proton radiotherapy in reducing gastrointestinal toxicity in the treatment of locally advanced unresectable pancreatic cancer of the headVijay P Raturi, Hidehiro Hojo, Kenji Hotta, et al.
Frontiers in Oncology|November 16, 2020
Dose-Volume and Radiobiological Model-Based Comparative Evaluation of the Gastrointestinal Toxicity Risk of Photon and Proton Irradiation Plans in Localized Pancreatic Cancer Without Distant MetastasisVijay P Raturi, Taku Tochinai, Hidehiro Hojo, et al.
Pageof 21